The largest database of trusted experimental protocols

7 protocols using anti cd44 im7

1

Profiling Tumor-Infiltrating Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze lymphoid populations within the tumor from one patient (patient 4), the fresh tumor tissue was finely minced with scissors and filtered through a nylon membrane, and a single-cell suspension was purified over a Ficoll–Hypaque density gradient. Cells were stained with the following anti-human antibodies: anti-αβTCR (IP26, eBioscience, San Diego, CA, USA), anti-CD8 (OKT8, eBioscience), anti-CD44 (IM7, eBioscience), anti-PD-1 (eBioJ105, eBioscience), anti-CD27 (O323, eBioscience), anti-CD20 (2H7, eBioscience), anti-CD1c (L161, eBioscience), anti-γδTCR (B1, BioLegend, San Diego, CA, USA), anti-CD4 (OKT4, BioLegend), anti-CD28 (CD28.2, BioLegend), anti-FAS (DX2, BioLegend), anti-ICOS (C398.4A, BioLegend), anti-IgM (MHM-88, BioLegend), anti-CD21 (B-ly4, BD Biosciences, San Jose, CA, USA), anti-CD23 (M-L233, BD Biosciences), and anti-IgD (Southern Biotech, Birmingham, AL, USA). Flow cytometry was performed using a BD FACS Canto II flow cytometer (BD Biosciences) and analyzed via FlowJo software (Tree Star, Ashland, OR, USA).
+ Open protocol
+ Expand
2

Murine Immune Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometric analysis and sorting, the following antibodies were purchased from BD Biosciences: anti-CD4 (RM4-5), anti-CD8a (53-6.7), anti-CD11c (HL3), anti-CD25 (PC61), anti-I-A/I-E (MHC class II, 2G9), anti-DO11.10 TCR (KJ1.26), anti-CD16/CD32 (2.4G2, for blocking Fc receptors) and anti-Thy1.1 (CD90.1, OX-7). The following antibodies were purchased from eBioscience: anti-CD80 (16-10A1), anti-CD86 (GL1), anti-LFA-1 (CD11a, M17/4), anti-ICAM-1 (CD54, YN1/1.7.4), anti-CD44 (IM7) and anti-Thy1.2 (CD90.2, 53-2.1). Anti-CD45RB (C363-16A) was purchased from BioLegend (San Diego, CA, USA). For reagents used in culture, anti-CD28 (37.51) and anti-CD3 (2C11) antibodies were purchased from BD Biosciences, and anti-CD40 (1C10) from eBioscience. For in vivo injections, anti-Thy1.2 (CD90.2, 30-H12) was purchased from BD Biosciences and also purified from ascites with hybridoma cells. Control rat IgG was purchased from Molecular Innovations (Novi, MI, USA).
+ Open protocol
+ Expand
3

Isolation of Antigen-Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
At day 50 or 100 after primary vaccination, or at day 10 after secondary vaccination, mice were sacrificed, spleens were isolated and passed through 70 μm cell strainer (BD Falcon). After erythrocyte lysis, cell suspensions were washed, stained with anti-CD8α mAb (53-6.7, eBioscience), anti-CD44 (IM7, eBioscience) and anti-CD62L (MEL-14, BD Pharmingen) and PE-conjugated H-2Db/E749-57 or H-2Kb/OVA257-264 tetramers and sorted on a BD FACSAria Fusion cell sorter. Live cells were selected based on propidium iodide exclusion. All samples were maintained at 4oC for the duration of the sort, and purity was at 95%-98% for all samples. Isolated cells were subsequently used for in vivo, in vitro, RNAseq or ChIPseq assays.
+ Open protocol
+ Expand
4

Comprehensive Antibody Panel for Murine T-cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies for flow cytometry were from BD bioscience (anti-B220 (RA3-6B2), anti-CD3ε (145-2C11), anti-CD8α (53-6.7), anti-CD4 (RM4-5), anti-CD44 (IM7), anti-CD25 (PC61) anti-Vα3.2(RR3-16), anti-Vα8.3(B21.14), anti-Vα2 (B20.1), anti-Vβ5.1/5.2(MR9-4), anti-Vβ8.1/8.2(MR5-2), anti-Vβ3(KJ25), anti-Vβ2(B20.6), anti-Vβ8.3(1B3.3), anti-Vβ6(RR4-7), anti-Vβ7(TR310), anti-RORχT (Q31-378), anti-PLZF (R17-809)), eBiosciences (anti-TCRβ(H57-597), anti-T-bet (eBio4B10)) and BioLegend (anti-CD122 (TM-β1), anti-CD127 (A7R34)). The BEko.8Z hybridoma, C6VL.22α-, C6VL51.β- and 58α-β-mutant cell lines have been described earlier (21 (link), 28 (link)).
+ Open protocol
+ Expand
5

Flow Cytometric Analysis of Spleen Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometric analysis was carried out on the spleens of the indicated animals. Spleens were passed through a 100μm cell strainer (Corning) and the red cells lysed. Samples were resuspended, FC receptors blocked (2.4G2, eBioscience) and surface antigens stained in HBSS (Life Technologies) alone or PBS (Life technologies) plus 0.5% (w/v) BSA (Sigma). The Foxp3 Transcription Factor Staining Buffer Set (eBioscience) was used for intracellular staining. The following stains and antibodies were used: Live/dead (Life Technologies), anti-CD4 (GK1.5, Tonbo Biosciences), anti-CD8 (53-67, Tonbo Bioscience), anti-CD11c (N418, eBioscience), anti-CD19 (6D5, eBioscience), anti-CD25 (PC61.5, eBioscience), anti-CD40L (MR1, eBioscience), anti-CD44 (IM7, eBioscience), anti-CD62L (MEL14, eBioscience), anti-CXCR5 (2G8, BD Bioscience), anti-FoxP3 (FJK-16s, eBioscience), PNA (Vector Laboratories), anti-GL7 (GL-7, eBioscience), anti-ICOS (7E.17G9, eBioscience), anti-IgD (11-26c, eBioscience), anti-IgM (eb121-15F9), anti-PD1 (J43, eBioscience), anti-DR3 (BAF2437, R&D) and anti-TL1A (Tan2-2, University of Southampton [19 (link)]). Samples were run for analysis on a BD FACSVerse and sorted on a BD FACS Aria II. Flow cytometrey data was analyzed with Flow Jo V9.
+ Open protocol
+ Expand
6

Characterization of CD8+ T Cell Phenotypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were prepared from the spleen, LNs, and surface or intracellularly stained as described (Shan et al., 2022a (link)). The fluorochrome-conjugated antibodies were as follows: anti-CD8 (53–6.7), anti-TCRβ (H57-597), anti-CD45.2 (104), anti-Granzyme B (GB12), anti-IFN-γ (XMG1.2), anti-Tbet (4B10), anti-CD62L (MEL-14), anti-KLRG1 (2F1), anti-CD25 (PC61.5), anti-CD69 (H1.2F3), and anti-CD44 (IM7) were from Thermo Fisher Scientific; anti-Tcf1 (C63D9) from Cell Signaling Technology; anti-IL-7Rα (A7R34) and anti-CD45.1 (A20) were from BioLegend. For detection of Tcf1 and Tbet proteins, surface-stained cells were fixed and permeabilized with the Foxp3/Transcription Factor Staining Buffer Set (eBiosciences, Thermo Fisher Scientific), followed by incubation with corresponding fluorochrome-conjugated antibodies. Apoptotic cells were detected with FLICA 660 Caspase-3/7 detection kit (Bio-Rad). Data were collected on FACSCelesta or FACSVerse (BD Biosciences) and were analyzed with FlowJo software V10.2 (TreeStar). For validation of CTCF deletion efficiency, cell lysates from sorted GFP+ naive or early effector CD8+ T cells were immunoblotted with anti-CTCF antibody (D31H2; Cell Signaling Technology) following standard protocols.
+ Open protocol
+ Expand
7

Multi-parameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were prepared from the spleen, lymph nodes (LNs), and surface or intracellularly stained as described54 . The fluorochrome-conjugated antibodies were as follows: anti-CD4 (RM4-5), anti-CD8 (53-6.7), anti-TCRβ (H57-597), anti-CD45.1 (A20), anti-CD45.2 (104), anti-CD62L (MEL-14), anti-IL-2Rβ (TM-β1), anti-IL-7Rα (A7R34), anti-Eomes (Dan11mag), anti-CD25 (PC61.5), anti-CD69 (H1.2F3), anti-ICOS (C398.4A), and anti-CD44 (IM7) were from Thermo Fisher Scientific; anti-γc (TUGm2) and anti-PD1 (RMP1-30) from BioLegend; anti-Tcf1 (C63D9) and anti-Lef1 (C12A5) from Cell Signaling Technology. For detection of Tcf1 and Lef1 proteins, surface-stained cells were fixed and permeabilized with the Foxp3/Transcription Factor Staining Buffer Set (eBiosciences), followed by incubation with corresponding fluorochrome-conjugated antibodies. For detection of cell survival status, the PE Annexin V Apoptosis Detection Kit (BD Biosciences) was used following the manufacturer’s instruction. Data were collected on FACSCelesta or FACSVerse (BD Biosciences) and were analyzed with FlowJo software V10.2 (TreeStar).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!